Chiesi Nordic
Linus Kjellqvist is an experienced digital marketing professional currently serving as the Nordic Digital Marketing Manager at Chiesi Nordic since January 2021. Prior to this role, Kjellqvist held positions such as Global Digital Communication Manager at Rehband and Marketing Manager, Co-founder at Aska Design Studio, where skills in content creation, brand communication, and digital strategy were demonstrated. Notable previous experience includes roles as Digital Manager at Svenska Turistföreningen and Head of Digital and Communication at Visma, showcasing expertise in digital marketing frameworks and enhancing brand experiences. Academic achievements include a Master's degree in Interaction Design from Chalmers University of Technology and certification as a Social Media Strategist from Berghs School of Communication.
Chiesi Nordic
1 followers
Chiesi is an international, privately-owned pharmaceutical company with its Corporate Head Office based in Parma, Italy. Chiesi is dedicated to the research, development and sales of innovative, therapeutic prescription medicines in the fields of respiratory, neonatology, transplant medicine and rare diseases. Founded in 1935, as a family firm, today, Chiesi spans the globe, employing more than 5000 people in 26 affiliates worldwide and distributes its products in more than 70 countries. In the Nordics, Chiesi Pharma AB employs more than 50 dedicated employees, who are based out of our head office in Central Stockholm, the recently integrated Research and Development Centre at Lidingö outside Stockholm or are part of our experienced field-based sales teams. As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability in everything we do. It emphasizes the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions. Chiesi is entering important new therapy areas, such as organ transplantation and rare diseases, alongside our treatments for respiratory conditions.